European Pharmaceutical Review
JANUARY 11, 2024
There is a clear trend away from developing pharmacological therapies targeting opioid receptors” There is a clear trend away from developing pharmacological therapies targeting opioid receptors. 2017; 6(S1):1–3. Neuropathic pain in adults: pharmacological management in non-specialist settings – NCBI Bookshelf.
Pharmaceutical Technology
NOVEMBER 17, 2022
This marks the first update to NICE’s endometriosis guidelines since 2017, representing a huge milestone for patients and practitioners alike. In response to their request, NICE conducted a surveillance review of the 2017 guidelines to evaluate whether their recommendations align with the current research and evidence.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 25, 2022
The eyedrop formulation of UNR844 (lipoic acid/choline ester chloride) was acquired as part of the group’s buyout of privately-held ophthalmology biotech Encore Vision for $375 million upfront in 2017, and was designed to work by restoring the elasticity of the eye’s lens that declines with age.
European Pharmaceutical Review
MARCH 11, 2024
With therapeutic expertise in HIV, hepatology and rare diseases, Sherene has additional expertise in clinical pharmacology and drug safety. Internet] 2017. Sherene has worked in the healthcare sector for more than 20 years, including in several leadership roles at GSK. Lancet HIV. 2023;10(5):e295-e307.
Legacy MEDSearch
AUGUST 25, 2022
Despite improvements in patient care pathways, widespread use of reperfusion strategies, and adjuvant pharmacological therapies, the one-year mortality rate after STEMI in high-risk patients has plateaued over the past decade at 14% [1]. The PiCSO Impulse System received ‘Breakthrough Designation’ from the FDA in 2019 and the CE-Mark in 2020.
European Pharmaceutical Review
JULY 27, 2023
Pharmacological therapies mainly address symptoms and unfortunately a significant number of patients do not respond adequately, progressing to congestive heart failure and eventually needing a heart transplant. Frontiers in Pharmacology. Nature Publishing Group; 2017 [Cited 2023Mar]. 1 Furthermore, there are 63.3 BMC Cancer.
Pharmaceutical Technology
FEBRUARY 8, 2023
Since the first approval in 2017, the FDA’s Office of Tissue and Advanced Therapies (OTAT) has approved 27 cell and gene therapies. One such example is Hemgenix (etranacogene dezaparvovec), the first gene therapy to treat adults with haemophilia B, which was approved in November.
Expert insights. Personalized for you.
86 
Let's personalize your content